URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Kishan Pandya

Concepts (262)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Antineoplastic Combined Chemotherapy Protocols
19
1982
429
2.560
Why?
Breast Neoplasms
20
1980
673
2.110
Why?
Lung Neoplasms
12
1986
439
1.640
Why?
Hot Flashes
4
2000
28
1.480
Why?
Carcinoma, Non-Small-Cell Lung
7
2000
72
1.350
Why?
Cyclohexanecarboxylic Acids
3
2004
48
1.100
Why?
Amines
3
2004
65
1.100
Why?
gamma-Aminobutyric Acid
3
2004
98
1.070
Why?
Tamoxifen
7
1994
81
1.000
Why?
Neoplasms
9
1988
739
0.850
Why?
Taxoids
2
2009
14
0.850
Why?
Neoplasm Metastasis
15
1980
228
0.830
Why?
Colonic Neoplasms
4
1986
124
0.790
Why?
Antineoplastic Agents
8
1982
619
0.780
Why?
Pain
4
1993
382
0.710
Why?
Analgesics
3
1993
117
0.680
Why?
Carboplatin
1
2009
30
0.670
Why?
Middle Aged
42
1980
9837
0.670
Why?
Fluorouracil
10
1986
78
0.660
Why?
Diphosphonates
1
2009
43
0.650
Why?
Imidazoles
1
2009
67
0.650
Why?
Carcinoma, Small Cell
1
2007
32
0.600
Why?
Sirolimus
1
2007
31
0.600
Why?
Aged
34
1982
7269
0.590
Why?
Female
47
1980
19838
0.580
Why?
Neoplasm Recurrence, Local
8
1980
288
0.580
Why?
Protein Kinase Inhibitors
1
2007
92
0.560
Why?
Radiation-Sensitizing Agents
4
2001
75
0.530
Why?
Menopause
2
1993
43
0.520
Why?
Aged, 80 and over
13
1993
2529
0.510
Why?
Paclitaxel
4
2001
58
0.500
Why?
Cisplatin
8
1986
95
0.490
Why?
Humans
57
1980
36274
0.480
Why?
Antineoplastic Agents, Phytogenic
4
2000
40
0.480
Why?
Selective Estrogen Receptor Modulators
1
2004
9
0.470
Why?
Acetates
1
2004
64
0.450
Why?
Adult
32
1982
11351
0.450
Why?
Treatment Outcome
12
1993
2615
0.440
Why?
Drug Administration Schedule
7
1998
366
0.380
Why?
Endometrial Neoplasms
1
2001
37
0.370
Why?
Clonidine
1
2000
34
0.360
Why?
Male
28
1980
19675
0.360
Why?
Neoplasm Staging
4
2007
338
0.360
Why?
Adrenergic alpha-Agonists
1
2000
37
0.350
Why?
Postmenopause
1
2000
43
0.350
Why?
Antineoplastic Agents, Hormonal
1
2000
46
0.350
Why?
Drug Prescriptions
2
1993
42
0.350
Why?
Rectal Neoplasms
3
1986
82
0.350
Why?
Etoposide
4
1995
83
0.340
Why?
Remission Induction
8
1989
161
0.320
Why?
Appetite Stimulants
1
1998
1
0.320
Why?
Megestrol Acetate
1
1998
1
0.320
Why?
Survival Rate
6
1998
618
0.310
Why?
Carcinoma, Renal Cell
1
1998
55
0.300
Why?
Interferon-alpha
1
1998
83
0.290
Why?
Minority Groups
1
1997
56
0.290
Why?
Kidney Neoplasms
1
1998
103
0.290
Why?
Ambulatory Care
2
1994
156
0.280
Why?
Pilot Projects
7
1985
442
0.280
Why?
Follow-Up Studies
8
1992
1855
0.280
Why?
Chemotherapy, Adjuvant
2
1994
88
0.260
Why?
Amenorrhea
1
1994
17
0.250
Why?
Double-Blind Method
4
2000
992
0.240
Why?
Nausea
3
1980
155
0.220
Why?
Cyclophosphamide
5
1982
174
0.220
Why?
Combined Modality Therapy
5
1985
486
0.210
Why?
Administration, Oral
3
2000
308
0.210
Why?
Vomiting
2
1992
115
0.210
Why?
Palliative Care
2
1989
159
0.210
Why?
Doxorubicin
5
1995
107
0.210
Why?
Proportional Hazards Models
3
2000
450
0.210
Why?
Research Design
2
1988
336
0.210
Why?
Vincristine
4
1982
62
0.200
Why?
Pain Measurement
2
1994
246
0.190
Why?
Survival Analysis
7
1993
606
0.190
Why?
Disease-Free Survival
3
1994
198
0.190
Why?
Canada
2
1994
75
0.180
Why?
Vitis
1
2010
3
0.180
Why?
Physician's Practice Patterns
1
1993
243
0.180
Why?
Adenocarcinoma
4
1995
439
0.180
Why?
Hospitals, Community
1
1990
70
0.170
Why?
Questionnaires
4
1993
1004
0.170
Why?
Beverages
1
2010
32
0.170
Why?
Mitomycin
4
1986
18
0.170
Why?
Time Factors
6
1980
3182
0.160
Why?
Spiro Compounds
1
1988
5
0.160
Why?
Fibroblast Growth Factor 7
1
2008
11
0.160
Why?
Pneumonectomy
1
2008
14
0.160
Why?
Antidepressive Agents
1
2009
93
0.160
Why?
Organometallic Compounds
1
1988
71
0.150
Why?
Liver Neoplasms
4
1980
151
0.150
Why?
Camptothecin
1
2007
8
0.150
Why?
Health Status Indicators
1
2008
107
0.150
Why?
United States
4
1988
2688
0.150
Why?
Head and Neck Neoplasms
1
2008
83
0.150
Why?
Drug Evaluation
8
1980
101
0.140
Why?
Drug Therapy, Combination
4
1982
382
0.140
Why?
Treatment Failure
1
2007
128
0.140
Why?
Infusions, Intravenous
4
1989
143
0.140
Why?
Carcinoma, Squamous Cell
1
2008
236
0.140
Why?
Neoplasms, Second Primary
1
2008
125
0.140
Why?
Patient Selection
1
2007
212
0.130
Why?
Placebos
2
2000
178
0.130
Why?
Vinblastine
2
1986
27
0.130
Why?
Procarbazine
1
2004
12
0.120
Why?
Disease Progression
2
2000
521
0.120
Why?
Severity of Illness Index
2
2004
922
0.110
Why?
Antimetabolites, Antineoplastic
2
1998
40
0.110
Why?
Thoracic Neoplasms
1
2003
19
0.110
Why?
Dysgerminoma
1
1982
8
0.110
Why?
Medical Oncology
2
1992
48
0.110
Why?
Mediastinal Neoplasms
1
1982
21
0.110
Why?
Prognosis
4
1985
1083
0.100
Why?
Recombinant Proteins
2
1998
723
0.100
Why?
Lymphatic Metastasis
3
1994
142
0.100
Why?
Megestrol
1
2001
3
0.100
Why?
Oncologic Nursing
2
1992
8
0.100
Why?
Professional Staff Committees
1
2001
7
0.100
Why?
Radiation Oncology
1
2001
18
0.090
Why?
Hyperaldosteronism
1
1980
5
0.090
Why?
Patient Dropouts
1
2000
26
0.090
Why?
Thioguanine
1
1980
15
0.090
Why?
Quality-Adjusted Life Years
1
2000
53
0.090
Why?
Immunotherapy, Active
1
1999
4
0.090
Why?
Methotrexate
4
1982
73
0.080
Why?
Cancer Vaccines
1
1999
33
0.080
Why?
Age Factors
2
1990
1128
0.080
Why?
Mitomycins
3
1986
17
0.080
Why?
Interleukin-1
1
1999
218
0.080
Why?
Tomography, X-Ray Computed
3
1982
759
0.070
Why?
Dose-Response Relationship, Radiation
2
2003
219
0.060
Why?
Prospective Studies
2
1993
1689
0.060
Why?
Menopause, Premature
1
1994
2
0.060
Why?
Stomach Neoplasms
1
1995
35
0.060
Why?
Menstruation
1
1994
16
0.060
Why?
Premenopause
1
1994
13
0.060
Why?
Ovariectomy
1
1994
45
0.060
Why?
Randomized Controlled Trials as Topic
2
1992
411
0.060
Why?
Ovary
1
1994
91
0.060
Why?
Multicenter Studies as Topic
1
1994
129
0.060
Why?
Fluoxymesterone
3
1997
4
0.060
Why?
Drug Utilization
1
1994
48
0.060
Why?
Goserelin
1
1993
7
0.060
Why?
Occult Blood
1
1993
8
0.060
Why?
Prostatic Neoplasms
2
1989
555
0.050
Why?
Health Services Needs and Demand
1
1994
103
0.050
Why?
Psychology, Clinical
1
1992
5
0.050
Why?
Analgesics, Opioid
1
1993
100
0.050
Why?
Drug Therapy
1
1992
46
0.050
Why?
Recurrence
2
1997
691
0.050
Why?
Regression Analysis
1
1993
527
0.050
Why?
Education, Medical
1
1993
136
0.050
Why?
Colorectal Neoplasms
1
1993
137
0.050
Why?
Mitosis
2
2000
99
0.050
Why?
Quality of Life
2
1998
502
0.050
Why?
Drugs, Investigational
1
1990
8
0.050
Why?
Indazoles
1
1990
6
0.050
Why?
Behavior Therapy
1
1992
98
0.050
Why?
Cell Cycle
2
2001
254
0.050
Why?
Tumor Stem Cell Assay
1
2010
24
0.050
Why?
Dose Fractionation
1
2010
60
0.050
Why?
Granulocyte Colony-Stimulating Factor
1
2010
44
0.050
Why?
Retrospective Studies
2
1985
2267
0.040
Why?
Translational Medical Research
1
2010
38
0.040
Why?
Health Knowledge, Attitudes, Practice
1
1993
267
0.040
Why?
Eating
1
2010
83
0.040
Why?
Bias (Epidemiology)
1
1990
44
0.040
Why?
Aminoglutethimide
1
1989
6
0.040
Why?
Tumor Cells, Cultured
2
2001
881
0.040
Why?
Flavonoids
1
2010
67
0.040
Why?
Sensitivity and Specificity
2
1993
905
0.040
Why?
Hydrocortisone
1
1989
131
0.040
Why?
Psychometrics
1
2010
223
0.040
Why?
Abdominal Neoplasms
1
2008
17
0.040
Why?
Mucositis
1
2008
13
0.040
Why?
Carcinoid Tumor
1
2008
26
0.040
Why?
Glutamates
1
2008
34
0.040
Why?
Adenoma
1
2008
54
0.040
Why?
Pituitary Neoplasms
1
2008
66
0.040
Why?
Self-Assessment
1
2008
52
0.040
Why?
Deoxycytidine
1
2008
28
0.040
Why?
Guanine
1
2008
50
0.040
Why?
Cell Line, Tumor
1
2010
575
0.040
Why?
Carcinoma
1
1989
191
0.040
Why?
Clinical Trials as Topic
2
1986
671
0.040
Why?
Oxazoles
1
1986
8
0.040
Why?
Isoxazoles
1
1986
17
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
1986
36
0.030
Why?
Antibiotics, Antineoplastic
1
1986
50
0.030
Why?
Cytosine
1
1986
32
0.030
Why?
Chronic Disease
1
2008
522
0.030
Why?
Anthracenes
1
1985
5
0.030
Why?
Leukopenia
1
1985
24
0.030
Why?
Physicians
1
1988
157
0.030
Why?
Risk Factors
2
1993
2345
0.030
Why?
New York
1
1990
1305
0.030
Why?
Hematologic Diseases
2
1986
39
0.030
Why?
Anthraquinones
1
1984
7
0.030
Why?
Reproducibility of Results
1
2008
877
0.030
Why?
Glucocorticoids
1
1986
162
0.030
Why?
Dose-Response Relationship, Drug
1
2008
1117
0.030
Why?
Mammary Neoplasms, Experimental
1
1986
239
0.030
Why?
Lung Diseases
1
1986
228
0.030
Why?
Risk Assessment
1
2008
884
0.030
Why?
Young Adult
1
2008
1059
0.030
Why?
Maximum Tolerated Dose
1
2003
17
0.030
Why?
G2 Phase
1
2003
30
0.030
Why?
Leucovorin
1
1982
12
0.030
Why?
Iodipamide
1
1982
9
0.030
Why?
Diatrizoate
1
1982
18
0.030
Why?
Diatrizoate Meglumine
1
1982
17
0.030
Why?
Prednisone
2
1986
165
0.030
Why?
Cytarabine
1
1982
89
0.030
Why?
Burkitt Lymphoma
1
1982
52
0.020
Why?
Mesothelioma
1
2001
30
0.020
Why?
Radiotherapy Dosage
1
2001
203
0.020
Why?
Organizational Objectives
1
2001
27
0.020
Why?
Aldosterone
1
1980
19
0.020
Why?
Spironolactone
1
1980
12
0.020
Why?
Ascites
1
1980
20
0.020
Why?
Diarrhea
1
2000
66
0.020
Why?
Axilla
1
2000
20
0.020
Why?
Likelihood Functions
1
2000
52
0.020
Why?
Serum Albumin
1
1980
96
0.020
Why?
Alkaline Phosphatase
1
1980
150
0.020
Why?
Forecasting
1
2001
177
0.020
Why?
Interprofessional Relations
1
2001
76
0.020
Why?
Blood Cell Count
1
1980
45
0.020
Why?
Hodgkin Disease
1
1982
155
0.020
Why?
Bilirubin
1
1980
68
0.020
Why?
Edema
1
1980
109
0.020
Why?
Cause of Death
1
2000
162
0.020
Why?
Hepatitis B Antibodies
1
1999
11
0.020
Why?
Europe
1
1999
80
0.020
Why?
Lipid A
1
1999
9
0.020
Why?
Mycobacterium
1
1999
7
0.020
Why?
Skin Tests
1
1999
29
0.020
Why?
Adolescent
1
2008
4766
0.020
Why?
Receptors, Estrogen
2
1984
178
0.020
Why?
Mitolactol
1
1998
6
0.020
Why?
Adjuvants, Immunologic
1
1999
117
0.020
Why?
Flow Cytometry
1
2000
603
0.020
Why?
Mastectomy
1
1997
43
0.020
Why?
Apoptosis
1
2003
823
0.020
Why?
Cohort Studies
1
2000
969
0.020
Why?
Bone Neoplasms
1
1998
207
0.020
Why?
Follicle Stimulating Hormone
1
1993
52
0.010
Why?
Gonadal Steroid Hormones
1
1993
35
0.010
Why?
Reagent Kits, Diagnostic
1
1993
15
0.010
Why?
Attitude of Health Personnel
1
1994
289
0.010
Why?
Mass Screening
1
1993
247
0.010
Why?
Gastrointestinal Diseases
1
1986
37
0.010
Why?
Central Nervous System Diseases
1
1986
57
0.010
Why?
Respiratory Function Tests
1
1986
121
0.010
Why?
Interferons
1
1986
48
0.010
Why?
Organ Size
1
1986
192
0.010
Why?
Progesterone
1
1986
97
0.010
Why?
Rats, Inbred Strains
1
1986
650
0.010
Why?
Mitoxantrone
1
1984
20
0.010
Why?
Bone Marrow
1
1986
287
0.010
Why?
Rats
1
1986
4289
0.000
Why?
Animals
1
1986
16093
0.000
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department